Ribalinine

Details

Top
Internal ID e8e1a7d4-a706-46e3-b86b-07aea2cb5152
Taxonomy Organoheterocyclic compounds > Quinolines and derivatives > Quinolones and derivatives > Pyranoquinolines
IUPAC Name (3S)-3-hydroxy-2,2,10-trimethyl-3,4-dihydropyrano[2,3-b]quinolin-5-one
SMILES (Canonical) CC1(C(CC2=C(O1)N(C3=CC=CC=C3C2=O)C)O)C
SMILES (Isomeric) CC1([C@H](CC2=C(O1)N(C3=CC=CC=C3C2=O)C)O)C
InChI InChI=1S/C15H17NO3/c1-15(2)12(17)8-10-13(18)9-6-4-5-7-11(9)16(3)14(10)19-15/h4-7,12,17H,8H2,1-3H3/t12-/m0/s1
InChI Key HUPKGVIVTBASQC-LBPRGKRZSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C15H17NO3
Molecular Weight 259.30 g/mol
Exact Mass 259.12084340 g/mol
Topological Polar Surface Area (TPSA) 49.80 Ų
XlogP 1.90
Atomic LogP (AlogP) 1.61
H-Bond Acceptor 4
H-Bond Donor 1
Rotatable Bonds 0

Synonyms

Top
7688-58-6
(S)-(-)-Ribalinine
DTXSID20998177
(3S)-3-hydroxy-2,2,10-trimethyl-3,4-dihydropyrano[2,3-b]quinolin-5-one
AKOS040753757

2D Structure

Top
2D Structure of Ribalinine

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9658 96.58%
Caco-2 + 0.7882 78.82%
Blood Brain Barrier + 0.6250 62.50%
Human oral bioavailability - 0.5000 50.00%
Subcellular localzation Lysosomes 0.4424 44.24%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9399 93.99%
OATP1B3 inhibitior + 0.9529 95.29%
MATE1 inhibitior - 0.9000 90.00%
OCT2 inhibitior - 0.9500 95.00%
BSEP inhibitior - 0.8517 85.17%
P-glycoprotein inhibitior - 0.9261 92.61%
P-glycoprotein substrate - 0.7775 77.75%
CYP3A4 substrate + 0.6412 64.12%
CYP2C9 substrate - 0.8052 80.52%
CYP2D6 substrate - 0.7700 77.00%
CYP3A4 inhibition - 0.8805 88.05%
CYP2C9 inhibition - 0.8829 88.29%
CYP2C19 inhibition - 0.6794 67.94%
CYP2D6 inhibition - 0.8766 87.66%
CYP1A2 inhibition + 0.7851 78.51%
CYP2C8 inhibition - 0.8838 88.38%
CYP inhibitory promiscuity - 0.8987 89.87%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9200 92.00%
Carcinogenicity (trinary) Non-required 0.4858 48.58%
Eye corrosion - 0.9913 99.13%
Eye irritation - 0.8226 82.26%
Skin irritation - 0.8093 80.93%
Skin corrosion - 0.9381 93.81%
Ames mutagenesis + 0.6300 63.00%
Human Ether-a-go-go-Related Gene inhibition - 0.4763 47.63%
Micronuclear + 0.5100 51.00%
Hepatotoxicity + 0.5428 54.28%
skin sensitisation - 0.8516 85.16%
Respiratory toxicity + 0.8333 83.33%
Reproductive toxicity + 0.8444 84.44%
Mitochondrial toxicity + 0.8250 82.50%
Nephrotoxicity + 0.5000 50.00%
Acute Oral Toxicity (c) III 0.6361 63.61%
Estrogen receptor binding + 0.8326 83.26%
Androgen receptor binding + 0.5234 52.34%
Thyroid receptor binding - 0.4881 48.81%
Glucocorticoid receptor binding - 0.5000 50.00%
Aromatase binding - 0.5683 56.83%
PPAR gamma + 0.6606 66.06%
Honey bee toxicity - 0.9363 93.63%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity + 0.7000 70.00%
Fish aquatic toxicity - 0.6007 60.07%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 97.97% 95.56%
CHEMBL2581 P07339 Cathepsin D 97.53% 98.95%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 94.54% 96.09%
CHEMBL1806 P11388 DNA topoisomerase II alpha 94.28% 89.00%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 93.91% 85.14%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 93.34% 91.11%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 90.17% 99.23%
CHEMBL3192 Q9BY41 Histone deacetylase 8 88.14% 93.99%
CHEMBL1293249 Q13887 Kruppel-like factor 5 85.54% 86.33%
CHEMBL5103 Q969S8 Histone deacetylase 10 82.22% 90.08%
CHEMBL253 P34972 Cannabinoid CB2 receptor 81.78% 97.25%

Cross-Links

Top
PubChem 932818
NPASS NPC284323
LOTUS LTS0069515
wikiData Q104403695